RadNet, Inc. Debt Instrument, Fair Value Disclosure
RadNet, Inc. (RDNT) had Debt Instrument, Fair Value Disclosure of $1.32 billion as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2026-08-10
- 2026-06-30: Debt Instrument, Fair Value Disclosure $1.32B.
- 2026-03-31: Debt Instrument, Fair Value Disclosure $1.08B.
- 2025-12-31: Debt Instrument, Fair Value Disclosure $1.08B.
- 2025-09-30: Debt Instrument, Fair Value Disclosure $1.09B.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2026-06-30 | $1.32B 10-Q · filed 2026-08-10 |
| 2026-03-31 | $1.08B 10-Q · filed 2026-05-11 |
| 2025-12-31 | $1.08B 10-Q · filed 2026-08-10 |
| 2025-09-30 | $1.09B 10-Q · filed 2025-11-10 |
| 2025-06-30 | $1.10B 10-Q · filed 2025-08-11 |
| 2025-03-31 | $1.00B 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.01B 10-K · filed 2026-03-02 |
| 2024-09-30 | $1.01B 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.02B 10-Q · filed 2024-08-09 |
| 2024-03-31 | $821.19M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $823.06M 10-K · filed 2025-03-03 |
| 2023-09-30 | $853.06M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $856.75M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $860.44M 10-Q · filed 2023-05-10 |
| 2022-12-31 | $864.13M 10-K · filed 2024-02-29 |
| 2022-09-30 | $757.94M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $761.25M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $764.56M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $767.88M 10-K · filed 2023-03-01 |
| 2021-09-30 | $771.19M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $774.13M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $651.58M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $662.40M 10-K · filed 2022-03-01 |
| 2020-09-30 | $673.23M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $684.05M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $694.88M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $705.70M 10-K · filed 2021-03-16 |
| 2019-09-30 | $716.52M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $726.97M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $637.42M 10-Q · filed 2019-05-10 |
| 2018-12-31 | $646.44M 10-K · filed 2020-03-16 |
| 2018-09-30 | $595.46M 10-Q · filed 2018-11-09 |
| 2018-06-30 | $603.73M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $612.00M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $620.27M 10-K · filed 2019-03-18 |
| 2016-12-31 | $478.94M 10-K · filed 2018-03-19 |
| 2015-12-31 | $451.02M 10-K · filed 2017-03-17 |
| 2015-03-31 | $394.56M 10-Q · filed 2015-05-11 |
| 2014-12-31 | $399.75M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |